Safety and Efficacy of Metformin for Therapy-induced Hyperglycemia in Children With Acute Lymphoblastic Leukemia

Bruce Bostrom(Minnesota West Community & Technical College), Robert C. McEvoy(Children's Minnesota), Laura M. Gandrud(Stanford University), Julie Chu(Palmetto Hematology Oncology), Priya A. Uppal(Palmetto Hematology Oncology), Yoav H. Messinger(Children’s Minnesota - St. Paul Hospital)

Journal of Pediatric Hematology/Oncology

July 3, 2013

10.1097/mph.0b013e31829cdeba

Cited by 27

Related Papers

A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

|Blood|2002|496

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

|Blood|2003|361

Association of Hypoglycemia, Hyperglycemia, and Glucose Variability With Morbidity and Death in the Pediatric Intensive Care Unit

|PEDIATRICS|2006|359

Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic Leukemia

|New England Journal of Medicine|1987|334

The genomic landscape of juvenile myelomonocytic leukemia

|Nature Genetics|2015|310